Latest schizophrenia Stories

Finding provides new drug development opportunity in this hard-to-treat disease Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments. A...

VANCOUVER, Aug. 7, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) today announced its unaudited operating results for the three and six-month periods ended June 30, 2012. Allon also said that its successful $10 million equity financing completed during the second quarter and ongoing progress in its pivotal clinical trial have kept the Company on track to achieve its objective of securing marketing approval for its lead neuroprotective drug candidate davunetide as a...

TOKYO, July 25, 2012 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas"; Tokyo:4503; President and CEO: Yoshihiko Hatanaka) and Fujita Health University (Aichi, President: Yoshikazu Kurosawa) announced that Astellas Research Institute of America LLC (ARIA), in collaboration with Dr. Tsuyoshi Miyakawa at Institute for Comprehensive Medical Science, Fujita Health University and Stanley Medical Research Institute (SMRI), has discovered deficits in maturation steps of neurogenesis within...

SEATTLE, July 18, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported that OMS824, the lead compound in the Company's phosphodiesterase 10 (PDE10) program for schizophrenia, has successfully completed all of the preclinical studies that Omeros expects will be necessary for the drug's planned Investigational New Drug Application (IND). OMS824 selectively inhibits PDE10, which is an enzyme expressed in areas of the brain linked to diseases that affect cognition,...

Johns Hopkins researchers say they have discovered a cause-and-effect relationship between two well-established biological risk factors for schizophrenia previously believed to be independent of one another. The findings could eventually lead researchers to develop better drugs to treat the cognitive dysfunction associated with schizophrenia and possibly other mental illnesses. Researchers have long studied the role played in the brain's neurons by the Disrupted-in-Schizophrenia 1...

TORONTO, July 17, 2012 /PRNewswire/ - Scientists have discovered two genetic variants associated with the substantial, rapid weight gain occurring in nearly half the patients treated with antipsychotic medications, according to two studies involving the Centre for Addiction and Mental Health (CAMH). These results could eventually be used to identify which patients have the variations, enabling clinicians to choose strategies to prevent this serious side-effect and offer more...

VANCOUVER, July 16, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced that data presented at the Alzheimer's Association International Conference (AAIC) in Vancouver confirm the integrity of patient enrollment and the importance of cognitive impairment in its pivotal clinical trial evaluating the Company's lead drug candidate davunetide as a potential treatment of the rapidly progressive neurodegenerative disease progressive supranuclear palsy (PSP). Dr. Michael...

Team Tiverity recently sponsored a home repair and cookout event in support of the Interfaith Outreach Home’s commitment to transition its residents from a homeless to hopeful and stable state. Atlanta, GA (PRWEB) July 13, 2012 According to the National Alliance to End Homelessness, there are over 600,000 homeless families in America, and over 7,000 in the Metro Atlanta area. That is why many Tiverity team members, including all of their top executives and their families, recently...

The week of August 6-10 is the third National Feeding Pets of the Homeless “Give a Dog a Bone” Week, sponsored by the national nonprofit, Pets of the Homeless. To find a collection site near you, visit their website. Carson City, NV (PRWEB) July 12, 2012 The week of August 6-10 is the third National Feeding Pets of the Homeless “Give a Dog a Bone” Week. The national organization, Pets of the Homeless, asks the public to locate a collection site in their community by visiting...

CHICAGO, July 12, 2012 /PRNewswire/ --The burden of homelessness has a way of stripping away hope. Ten years ago, a small group of people with tremendous energy and compassion came together to form La Casa Norte (LCN), making a promise to provide hope for Chicago's homeless youth and families. Today, the organization along with founding member, Keith Decker, and executive director, Sol A. Flores, will be honored at the White House for their leadership and commitment to homeless...